Sunitinib
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8406 publications
Efficacy of ripretinib in advanced gastrointestinal stromal tumor and treatment options after resistance: a retrospective real-world study
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: September 07, 2026
Evaluating bezuclastinib for the treatment of advanced gastrointestinal stromal tumours.
Journal: Expert opinion on pharmacotherapy
Published: September 03, 2026
XY0206 targets FLT3-dependent resistance states in acute myeloid leukemia.
Journal: The Journal of clinical investigation
Published: September 01, 2026
Cost‑effectiveness of first‑line immunotherapy-based combination regimens for advanced renal cell carcinoma in China and the United States.
Journal: Human vaccines & immunotherapeutics
Published: August 22, 2026
Molecularly imprinted nanocomposite sensor for sensitive and selective electrochemical detection of sunitinib.
Journal: Analytical methods : advancing methods and applications
Published: August 06, 2026
Succinic Acid-Sunitinib Combination Treatment Downregulates the Angiogenic Gene Expressions in Sunitinib- Resistant Renal Cancer Cell Line.
Journal: Cell biochemistry and biophysics
Published: July 18, 2026
YTHDF1-mediated translational activation of SETD2 suppresses aerobic glycolysis and sensitizes renal cell carcinoma to sunitinib.
Journal: Cellular signalling
Published: July 17, 2026
Machine learning of sunitinib resistance genes reveals that SP5 regulates angiogenesis and sunitinib resistance in RCC via the VEGFA/AKT axis.
Journal: Neoplasia (New York, N.Y.)
Published: July 14, 2026
RETRACTED: Mohamad et al. Secukinumab and Black Garlic Downregulate OPG/RANK/RANKL Axis and Devitalize Myocardial Interstitial Fibrosis Induced by Sunitinib in Experimental Rats. Life 2023, 13, 308.
Journal: Life (Basel, Switzerland)
Published: July 07, 2026
Super-resolution imaging with a mitochondria-targeted fluorescent probe: Evaluation of chemotherapy-induced hepatorenal injury.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: July 01, 2026
DERL3 Predicts and Drives Acquired Sunitinib Resistance in Renal Cell Carcinoma by Suppressing ER Stress-ROS-Dependent Apoptosis.
Journal: Biomedicines
Published: July 01, 2026
Last Updated: 09/26/2026